Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Microbiol Immunol ; 64(6): 416-423, 2020 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-32190917

RESUMEN

Papillomatous digital dermatitis (PDD) is a foot disease causing lameness in dairy cattle. It is regarded as a polymicrobial infection, although its etiology is not fully understood. PDD is treated by the topical or systemic administration of antibiotics such as lincomycin (LCM); however, the milk of the cows cannot be marketed during the treatment and withdrawal period due to the residual antibiotics in milk. Allyl isothiocyanate (AITC), an extract of Wasabia japonica (known as wasabi or Japanese horseradish) widely employed as a food additive, can be used as an alternative antimicrobial agent that overcomes this problem. We previously showed that AITC is as effective as LCM in PDD treatment. Here, using the samples obtained in the previous clinical study, we analyzed changes in the bacterial population in the PDD-associated microbiota after AITC treatment and compared those with that following LCM treatment by 16S ribosomal RNA (rRNA)-based amplicon analysis. Both treatments induced major changes in the bacterial population, and Treponema species, which have been regarded as the major causative agents of PDD, were efficiently eliminated by both agents. However, the AITC-treated samples exhibited higher diversity compared with pretreatment samples, but this trend was not observed for LCM treatment, probably reflecting different antibacterial activities of the two agents. Importantly, this analysis detected population changes before morphological changes in PDD lesions (clinical signs of healing) became evident, indicating that 16S rRNA-based amplicon analysis represents an efficient strategy for analyzing and monitoring the treatment efficiency of PDD as well as other polymicrobial diseases.


Asunto(s)
Antibacterianos , Enfermedades de los Bovinos/tratamiento farmacológico , Coinfección/tratamiento farmacológico , Dermatitis Digital/tratamiento farmacológico , Isotiocianatos , RNA-Seq/métodos , Treponema , Administración Tópica , Animales , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Bovinos , Femenino , Isotiocianatos/farmacología , Isotiocianatos/uso terapéutico , Lactancia , Leche/química , ARN Ribosómico 16S/genética , Treponema/efectos de los fármacos , Treponema/genética , Wasabia/metabolismo
2.
J Nutr Biochem ; 76: 108265, 2020 02.
Artículo en Inglés | MEDLINE | ID: mdl-31760227

RESUMEN

Pioglitazone is one of the thiazolidinediones (TZDs) and an insulin-sensitive drug for type 2 diabetes. In our previous study, a combination of pioglitazone and fish oil rich in n-3 polyunsaturated fatty acids (PUFAs) was shown to inhibit pioglitazone-induced side effects, such as accumulation of subcutaneous fat and body weight gain. However, the effects of the discontinuation of fish oil after combination treatment with TZD and fish oil are not clear. In this study, discontinuation of fish oil for 4 weeks showed several unfavorable effects: (1) return of plasma adiponectin level, (2) reversal of the inhibition of lipogenesis and activation of fatty acid ß-oxidation in liver, (3) increase in hypertrophic adipocytes in epidydimal white adipose tissue (WAT) and (4) accumulation of lipids in brown adipose tissue (BAT). However, insulin resistance was ameliorated by pioglitazone with or without fish oil treatment and the discontinuation of fish oil. These findings indicate that discontinuation of n-3 PUFA after combination therapy with TZDs adversely affects lipid metabolism and energy homeostasis in liver, epididymal WAT and BAT.


Asunto(s)
Adiponectina/metabolismo , Diabetes Mellitus Experimental/tratamiento farmacológico , Aceites de Pescado/administración & dosificación , Resistencia a la Insulina , Pioglitazona/administración & dosificación , Adiponectina/sangre , Tejido Adiposo Pardo/metabolismo , Tejido Adiposo Blanco/metabolismo , Animales , Peso Corporal , Diferenciación Celular , Homeostasis , Metabolismo de los Lípidos , Hígado/metabolismo , Masculino , Ratones , Oxígeno/metabolismo
3.
J Food Drug Anal ; 26(4): 1265-1274, 2018 10.
Artículo en Inglés | MEDLINE | ID: mdl-30249325

RESUMEN

The elderly patients with type 2 diabetes suffer more adverse drug events than young adults due to pharmacokinetic and pharmacodynamic changes associated with aging. Reducing the risks of these medication-related problems are equally important for the clinical care of older type 2 diabetes patients. Pioglitazone is used for treating type 2 diabetes as an oral antidiabetic drug. Despite pioglitazone is used helpful insulin sensitizers, the accumulation of subcutaneous fat is considered a major adverse effect of pioglitazone therapy. We investigated to reduce the adverse effect of pioglitazone by combination with fish oil rich in eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in aged diabetic KK mice. The accumulation of subcutaneous fat associated with high-dose pioglitazone is reduced by fish oil, suppressing lipogenesis and stimulating fatty acid ß-oxidation in the liver. Our data suggest that adding fish oil to low-dose pioglitazone results in antidiabetic efficacy similar to that of the high-dose without concomitant body weight gain.


Asunto(s)
Envejecimiento/efectos de los fármacos , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Aceites de Pescado/administración & dosificación , Hipoglucemiantes/administración & dosificación , Pioglitazona/administración & dosificación , Envejecimiento/metabolismo , Animales , Diabetes Mellitus Tipo 2/metabolismo , Ácidos Docosahexaenoicos/administración & dosificación , Ácidos Docosahexaenoicos/análisis , Quimioterapia Combinada , Ácido Eicosapentaenoico/administración & dosificación , Ácido Eicosapentaenoico/análogos & derivados , Ácido Eicosapentaenoico/análisis , Ácidos Grasos/metabolismo , Aceites de Pescado/análisis , Humanos , Insulina/metabolismo , Lipogénesis/efectos de los fármacos , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Ratones
4.
J Vet Med Sci ; 79(7): 1191-1195, 2017 Jul 07.
Artículo en Inglés | MEDLINE | ID: mdl-28552873

RESUMEN

Bovine digital dermatitis (BDD) is the most prevalent infectious cause of lameness in cattle. Because Treponema infection is a major etiology of BDD, the most common treatment of BDD is an antibiotic. Nonetheless, dairy cows require a withdrawal period after antibiotic treatment before their milk can be marketed. To address the problem, in this study, we tested whether 3 nonantibiotic agents (used separately)-allyl isothiocyanate (AITC), sodium alginate, and calcium hydroxide-alleviate BDD lesions in dairy cows. The AITC treatment improved the BDD lesions, whereas the sodium alginate and calcium hydroxide treatments did not. Therapeutic efficacy of AITC was similar to that of lincomycin, a topical antibiotic prescribed for BDD. These results suggest that AITC is a promising nonantibiotic agent for BDD treatment in dairy cows.


Asunto(s)
Enfermedades de los Bovinos/tratamiento farmacológico , Dermatitis Digital/tratamiento farmacológico , Isotiocianatos/uso terapéutico , Alginatos/uso terapéutico , Animales , Hidróxido de Calcio/uso terapéutico , Bovinos , Femenino , Ácido Glucurónico/uso terapéutico , Ácidos Hexurónicos/uso terapéutico , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...